Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

NARecruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

March 30, 2027

Conditions
Malignant Neoplasm of Breast
Interventions
DEVICE

Novilase Laser ablation

Image-guided, percutaneous laser ablation of breast tumors

Trial Locations (11)

8008

ACTIVE_NOT_RECRUITING

Breast Centre Zurich, Zurich

8091

RECRUITING

University Hospital Zurich, Zurich

14203

RECRUITING

Buffalo General Medical Center, Buffalo

20889

WITHDRAWN

Walter Reed National Military Medical Center, Bethesda

50935

RECRUITING

St. Elisabeth-Krankenhaus Köln-Hohenlind, Cologne

69120

NOT_YET_RECRUITING

Heidelberg University Hospital, Heidelberg

91010

WITHDRAWN

City of Hope, Duarte

92037

RECRUITING

UC San Diego Health, La Jolla

92270

RECRUITING

Eisenhower Health, Rancho Mirage

06511

RECRUITING

Yale University, New Haven

07932

NOT_YET_RECRUITING

Summit Health, Florham Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novian Health Inc.

INDUSTRY

NCT03463954 - Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors | Biotech Hunter | Biotech Hunter